Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins - Wikidata - wikimedia - TriplyDB

Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins

Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins

http://www.wikidata.org/entity/Q36477398

about

Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease.Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.Di-tyrosine cross-link decreases the collisional cross-section of aβ peptide dimers and trimers in the gas phase: an ion mobility study.Increased ω6-Containing Phospholipids and Primary ω6 Oxidation Products in the Brain Tissue of Rats on an ω3-Deficient Diet Bis(sulfosuccinimidyl) suberate (BS3) crosslinking analysis of the behavior of amyloid-β peptide in solution and in phospholipid membranes.Links between copper and cholesterol in Alzheimer's disease.Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system Interaction of aldehydes derived from lipid peroxidation and membrane proteins Mutant presenilin 1 increases the expression and activity of BACE1 Antioxidants in central nervous system diseases: preclinical promise and translational challenges.Therapeutics for Alzheimer's disease based on the metal hypothesis Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity Mitochondrial dysfunction and oxidative stress in aging and cancer.Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.Amyloid-β production: major link between oxidative stress and BACE1.Cellular membrane fluidity in amyloid precursor protein processing.Chemical alterations and regulations of biomolecules in lifestyle-related diseases.Amyloid-β(1-42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity.The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells.Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis Sequestration of copper from beta-amyloid promotes selective lysis by cyclen-hybrid cleavage agents.Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity.Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.Amyloid Plaque-Associated Oxidative Degradation of Uniformly Radiolabeled Arachidonic Acid.Oxidative stress and the amyloid beta peptide in Alzheimer's disease.The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.A single cysteine post-translational oxidation suffices to compromise globular proteins kinetic stability and promote amyloid formation.Copper-Aβ Peptides and Oxidation of Catecholic Substrates: Reactivity and Endogenous Peptide Damage.Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.Effect of agitation on the peptide fibrillization: Alzheimer's amyloid-β peptide 1-42 but not amylin and insulin fibrils can grow under quiescent conditions.Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.S-Adenosylmethionine Attenuates Oxidative Stress and Neuroinflammation Induced by Amyloid-β Through Modulation of Glutathione Metabolism.Biochemical properties of cholesterol aldehyde secosterol and its derivatives.Role of amyloid-β–metal interactions in Alzheimer’s disease

P2860

Q30489145-61BB352B-A934-4968-A743-18C9ED6AE544 Q33634200-0FF22FED-9317-43F6-9B37-7AE647081C20 Q34193337-42924230-5A33-4936-8E2D-402FC66049A0 Q34440371-5A16A7B3-E543-44FE-B7F8-85F24E1A9CCC Q34549266-22663673-CDD4-4D5C-94BD-9529DBBE6A53 Q35191297-F7145F80-F5E9-4C13-B865-6DDB71C6486B Q36176078-EE5E4451-7768-4298-9244-3F4DB5B05D83 Q36316388-B53B3AF4-C6CD-413A-8C55-A85F2C7E4A7C Q36847737-AB213156-C77A-4C5A-946E-07263791211F Q36961203-22108557-41BF-4FDF-B8AA-ED85DDF8E935 Q37142547-4E1E9CBE-8858-4072-BFFD-E8DFCA7011EC Q37152818-76EF2F84-1241-4271-92A4-DCDAD81711EC Q37159979-EF4D7408-D9A8-43B0-A02C-82E37E3248B6 Q37215856-EA144017-51AB-424B-9CF8-F9E7486B13C4 Q37372156-FC702E61-5EFF-4198-990B-94F994A00A32 Q37413594-8BBC57EA-718F-45A7-B8CB-D0C676E24854 Q37564295-9E95E7CA-08A5-4AE0-8FB1-5C5E5359793C Q37847817-B70631F9-8297-48FF-975D-8FE1A1B04348 Q37946306-1B6231A5-FCCC-45C6-9E61-08D8F0155B6F Q38189670-0317D5E7-5CF3-468A-AB69-C1F4230DBD3E Q38726420-9EBE672E-6C4B-4CA6-931B-84EBA9C35562 Q38755870-32779D45-EF0F-4E11-B99F-3DA483735440 Q39369410-999778EB-ABC3-4BA3-8745-56AA62A47AD6 Q39545823-588F0096-5C91-49D3-956F-6CEDA189ABEA Q39756716-CDECBEB7-117C-41DA-9533-C6054FEAEB66 Q39947061-E92FCEC9-1F99-46EC-ABBC-DDBAB305F768 Q40095201-5F8E0187-D0DD-4C77-B4BF-A9C67F2DEEB0 Q40683231-4DB6A094-6758-43C3-8809-F109AFC0E76F Q42641035-398F8339-4620-48CD-8BCF-9A18D04706D6 Q46272723-A7553561-A610-49BE-9D76-400861E0A4CD Q46923380-591956CB-9144-46E0-8A4A-7A9832D52971 Q47408751-8AA27D91-79BA-4450-8B56-DE61512599DD Q48304306-919E219B-9197-4EA4-B471-935940D4FDA5 Q50288922-9339E675-6067-4513-9656-86246ED3A1C6 Q51050663-B28DF367-B310-4215-AE8C-FF22DFCC72A1 Q51759414-9ABA5529-DCD7-461D-834C-BB877D4E0C31 Q52373518-A59DE36C-24F6-490F-9740-5A0453834F5F Q52875305-E6EEDD64-178C-4037-A965-22E90B24824D Q55193003-D638F224-97CC-43C3-B771-8446ECEAEEFE Q58842294-FDBFFFED-0D10-4B17-8D53-674737FEB1F8

P2860

Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins

http://www.wikidata.org/entity/Q36477398

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@ast

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@en

type

label

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@ast

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@en

prefLabel

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@ast

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@en

P1433

Q36477398-4B89E131-4714-4EDD-BEFD-9231B4AD6E64

P1476

Q36477398-BFBAA11A-5A4D-4BD0-B752-399325D08D66

P2093

Q36477398-2F4A52E5-1ABC-4CED-AB7B-EDBECB15D24E

Q36477398-32EADCE3-07A9-4442-98BF-0B5289ED43C7

Q36477398-52321C25-B069-4226-B5B3-580975B3780E

Q36477398-691A280A-B86C-4DB9-8D53-580C7956E975

Q36477398-6C14F76F-F36B-4F6E-90C9-71ECCBFA6E42

Q36477398-9D11D3AB-0686-41E8-8F3A-809FF989DA7E

Q36477398-F68F245C-775F-4D11-9FD8-328139D2BDBC

P2860

Q36477398-06B0B8CF-7B3D-46FA-8054-583DA4060CA9

Q36477398-10CB9E13-C6E1-4BC3-B107-A037B91B9EDA

Q36477398-11A07BE5-F1D4-478D-90DE-30104863C8BF

Q36477398-12DD111B-5CE7-4FBF-BC34-1AB6AE35CFEC

Q36477398-1953D7AF-31AA-48CB-9415-04DFCDA13E96

Q36477398-1AAE6846-D18D-4F79-8683-43161D67B509

Q36477398-1E80A96E-BB15-40B0-9810-78800111786B

Q36477398-1E993339-573B-428D-8601-921F019D19CF

Q36477398-1F3496E2-D05A-4DF0-8208-81C10E58BB35

Q36477398-26F4B0CE-AB81-4514-9DFF-B0FF8ED7E8DD

P304

Q36477398-876C9413-A200-4701-A012-D0FFD256D211

P31

Q36477398-AE47506B-D4FA-45F3-BD8F-3FA55D993D39

P356

Q36477398-8859ABAD-0F18-47C9-B81A-77BE5AB41BA7

P407

Q36477398-649AA6DE-8C71-4946-AD0F-6A96A45B6B8A

P433

Q36477398-EF9FD9E4-B459-48BD-8703-AF05B8221A3E

P478

Q36477398-8BC6D537-8795-4B72-8A79-89833E641D4D

P577

Q36477398-47C8E0EB-F589-46A9-A7F4-908D17629F0C

P698

Q36477398-E128BFB8-9448-4EFB-920B-9FDA87054811

P932

Q36477398-9AFB634D-5F70-43E6-80DF-8FEE390C4AF5

P356

P1433

Journal of Biological Chemistry

P1476

Membrane-mediated amyloidogene ...... amage by amyloid beta proteins

@en

P2093

Gang Xiao

http://www.w3.org/2001/XMLSchema#string

Hiroaki Komatsu

http://www.w3.org/2001/XMLSchema#string

Ian V J Murray

http://www.w3.org/2001/XMLSchema#string

John A Lawson

http://www.w3.org/2001/XMLSchema#string

Kunihiro Uryu

http://www.w3.org/2001/XMLSchema#string

Liu Liu

http://www.w3.org/2001/XMLSchema#string

Paul H Axelsen

http://www.w3.org/2001/XMLSchema#string

P2860

A simple method for the isolation and purification of total lipides from animal tissues

Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal.

Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins.

Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1-42 oligomers.

Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein.

Effects of vitamin E on lipid peroxidation in healthy persons.

ProteinChip array-based amyloid beta assays.

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.

Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD.

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.

P304

9335-9345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M608589200

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17255094

http://www.w3.org/2001/XMLSchema#string

P932

2253689

http://www.w3.org/2001/XMLSchema#string